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Background
Biliary stones are a common disease in western countries,
and its management has changed dramatically over the
past decade. Due to the increase of the middle-aged peo-
ple, a larger number of elderly patients are affected by this
disease. Laparoscopic cholecystectomy (LC) represents the
gold standard for the treatment of gallbladder stones, and
in cholecystectomized patients, the treatment of CBD
stones remains the exclusive work of the endoscopist. But
if the patient still has the gallbladder with stones, the ideal
management of CBD stones remains controversial. There
are two treatment options: the two time (LC and pre or
postoperative ERCP), and the one time procedures (trans
cystic approach and CBD exploration and laparoendo-
scopic procedure called “rendezvous”:RV). The aim of the
work is to analyse our results of the mininvasive treatment
of the cholecysto-choledocolithiasis in elderly patients.
Materials and methods
In the period between September 2008 and November
2010, all patients affected by CBD stones and admitted
to the Department of Emergency Surgery of Cannizzaro
Hospital in Catania, were analyzed, and from this group
patients aged >65 years were considered for the present
study. Age, sex, main clinical data, history, diagnosis,
type of treatment, postoperative complications, length of
hospital stay and mortality were recorded. Patients
affected by cholecysto-choledocolithiasis were submitted
to the LC and RV technique. If the patients couldn’tb e
submitted to this procedure because of high anaesthetic
risks, ERCP was performed. However ERCP was always
performed in cholecistectomized patients with jaundice,
biliary pancreatitis, cholangitis and imaging showing
CBD stones.
Results
In the period of the study we observed 68 patients with
CBD stones, 37 were older than 65 years: 15 (40.5%)
males and 22 (59.5%) female, with a mean age of 76.45
years (range 65 -93). Twelve (32.4%) patients were trea-
ted by LC and intraoperative clearance of the CBD by the
RV. ERCP was performed in 22 (59.5%) patients: 8
(21.6%) previous cholecistectomized and 14(63.6%) who
still had their gallbladder, but with high anaesthetic risk.
In one patient the RV technique failed and laparoscopic
choledocotomy was performed and a T-tube left in situ,
but after 3 week trans-Kher cholangiography showed
residual stones, so the patient was submitted to ERCP. In
other two cases only LC was performed because the
papilla of Vater was difficult to approach. The length of
hospital stay was on average 7 days. Postoperative com-
plications occurred in 7(20%) patients: one patient devel-
oped post-ERCP pancreatitis, two patients post-ERCP
increasing of sieric amylase and lipase, three patients
with early stones recurrence, one patient developed post-
ERCP cholecystitis. Only one death was recorded.
Conclusions
For the treatment of the cholecysto-choledoco lithiasis, the
RV technique is the best option,e v e ni nt h ee l d e r l y ,b e c a u s e
the morbidity and the risk of iatrogenic damage seem lower
than ERCP. However in an older high risk patient the
ERCP remains a good therapeutical option, achieving an
acceptable risk of postoperative complications.
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